Articles by Disease (Fatigue Syndrome, Chronic)

Drugs to Treat Neuroinflammation in Neurodegenerative Disorders

Journal: Current Medicinal Chemistry
Volume: 31
Page: 1818-1829
Author(s): Yao-Chin Wang, Woon-Man Kung, Yi-Hsiu Chung* and Sunil Kumar*

Unlocking the Benefits of Fasting: A Review of its Impact on Various Biological Systems and Human Health

Journal: Current Medicinal Chemistry
Volume: 31
Page: 1781-1803
Author(s): Rawan Mackieh, Nadia Al-Bakkar, Milena Kfoury, Nathalie Okdeh, Hervé Pietra, Rabih Roufayel, Christian Legros, Ziad Fajloun* and Jean-Marc Sabatier*

An Update on the Role of Circadian Rhythms in Sleep Disorders

Journal: Current Drug Therapy
Volume: 19
Page: 302-316
Author(s): Namra Aziz, Vipin Kumar Garg, Yadav Rupali Vinod, Arpit Gupta, Ankita Wal, Shruti Rathore and Pranay Wal*

Beyond the Dusty Fog: Local Eye Drop Therapy and Potentially New Treatment Alternatives in Pseudoexfoliative Glaucoma

Journal: Current Medicinal Chemistry
Volume: 31
Page: 1608-1619
Author(s): Marco Zeppieri* and Mutali Musa

Role of Omega-3PUFA: A Nutraceutical for Brain Functioning and Treatment of Mental Disorders

Journal: Current Indian Science
Volume: 1
Page: 1-15
Author(s): Ishu Garg, Raj Kumari* and Meenakshi Sharma

Neurobiological Staging with Special Reference to Sleep Apnoea Syndrome: An Update

Journal: Current Indian Science
Volume: 1
Page: 1-8
Author(s): Anuj Kumar Sharma and Mayank Kulshreshtha*

Infectious Mononucleosis: An Updated Review

Journal: Current Pediatric Reviews
Volume: 20
Page: 305-322
Author(s): Alexander K.C. Leung*, Joseph M. Lam and Benjamin Barankin

Potential Benefits of Psilocybin for Lupus Pain: A Case Report

Journal: Current Rheumatology Reviews
Volume: 20
Page: 97-99
Author(s): Sofia Audrey B. Gonzales, Christine Alexopoulos and Daniel G. Arkfeld*

Current Insight into Novel Delivery Approaches of Resveratrol for Improving Therapeutic Efficacy and Bioavailability with its Clinical Updates

Journal: Current Pharmaceutical Design
Volume: 29
Page: 2921-2939
Author(s): Ranjit K. Harwansh*, Paras Yadav and Rohitas Deshmukh

AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans

Journal: Current Pharmaceutical Design
Volume: 29
Page: 2752-2762
Author(s): Israa M. Shamkh*, Mahmoud Elkazzaz, Enas. S. Radwan, Jawayria Najeeb, Md. Tabish Rehman, Mohamed F. AlAjmi, Moayad Shahwan, Muhammad Sufyan, Nouf Khalifa Alaqeel, Ibrahim A. Ibrahim, Basit Jabbar, Mohammad Shahbaz Khan, Tomasz M. Karpiński, Abdullah Haikal*, Reem M. Aljowaie, Saeedah Musaed Almutairi and Amr Ahmed